Marketable Securities, Current of Amylyx Pharmaceuticals, Inc. from 31 Dec 2023 to 31 Dec 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of investment in marketable security, classified as current.
Summary: Amylyx Pharmaceuticals, Inc. quarterly Marketable Securities, Current in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
Amylyx Pharmaceuticals, Inc. Marketable Securities, Current for the quarter ending 31 Dec 2025 was $90,328,000, a 8.9% decline year-over-year.
Source SEC data: View on sec.gov

Marketable Securities, Current, Quarterly (USD)

Marketable Securities, Current, YoY Quarterly Change (%)

Amylyx Pharmaceuticals, Inc. Quarterly Marketable Securities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q4 2025	$90,328,000	-$8,782,000	-8.9%	31 Dec 2025	10-K	03 Mar 2026	2025	FY
Q3 2025	$118,812,000	-$43,744,000	-27%	30 Sep 2025	10-Q	06 Nov 2025	2025	Q3
Q2 2025	$122,741,000			30 Jun 2025	10-Q	07 Aug 2025	2025	Q2
Q1 2025	$144,304,000			31 Mar 2025	10-Q	08 May 2025	2025	Q1
Q4 2024	$99,110,000	-$102,051,000	-51%	31 Dec 2024	10-K	03 Mar 2026	2025	FY
Q3 2024	$162,556,000			30 Sep 2024	10-Q	07 Nov 2024	2024	Q3
Q4 2023	$201,161,000			31 Dec 2023	10-K	04 Mar 2025	2024	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.